Highmark Health, Bosch partner in research that will use AI to identify lung disease in children

Highmark Health has announced a partnership with Bosch Group to research the use of sound analysis to diagnose lung disease in children.

The collaboration was unveiled at CES 2022 in Las Vegas this week. The study will begin on a small cohort of pediatric patients on the Allegheny Health Network in the first quarter of this year. Microphones will collect breathing pattern data that will be analyzed using artificial intelligence and machine learning to detect conditions such as asthma. The same Bosch technology is currently being used on the International Space Station.

During patients’ visits to the pediatric clinic, a microphone will capture children’s breathing patterns as they speak and breathe. These sounds will then be analyzed and added to AI and machine learning techniques with clinical details about the patient.

The collaborators say the research is based on traditional principles of listening to patients’ breasts with a stethoscope. AI technology could improve home care, where diagnostic results could be shared with a physician who could further examine any abnormality and make recommendations accordingly.

RELATED: Industrial Voices – Why the COVID-19 Pandemic Was a Landmark Moment for Machine Learning

“This unique collaboration between two industry leaders fits perfectly with our mission to explore technological innovations that can improve the health and well-being of our patients and members,” said Kelly J. Shields, Ph.D., senior research data researcher at Highmark Health, said in a statement.

“Bosch’s global leadership in the development of cutting-edge industrial and consumer technologies and Highmark Health’s R & D expertise, coupled with AHN’s leading pediatric expertise, is an incredibly promising combination that we believe can help transform the diagnosis and treatment of asthma and other respiratory disorders,” said Shields.


Give a Comment